clinical trial · NCT05572879
A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults
EuBiologics Co.,Ltd·phase3·completed·n = 2,600
COVID-19EuCorVac-19ChAdOx1 nCoV-19
brief summary
This is a phase III, randomized, observer-blind, active-controlled, parallel group, multi-center study to compare the immunogenicity and safety of a preventive COVID-19 vaccine EuCorVac-19 to ChAdOx1 in healthy adults aged 18 years and older
started
Oct 1, 2022
primary completion
Jun 23, 2023
completion
Feb 9, 2024
last updated
Jun 17, 2024
official title
A Phase III, Randomized, Observer-blind, Active-controlled, Parallel-group, Multi-center Study to Evaluate Immunogenicity and Safety of a Preventive COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol